FDA Extends Review for Lipocine's TLANDO; Advisory Committee Meeting Date of January 10, 2018 Rem… Post author:Sam Post published:November 16, 2017 Post category:BioPharma The FDA has assigned a new Prescription Drug User Fee Act goal date of May 8, 2018. Source: BioSpace You Might Also Like Zomedica Announces First Quarter 2017 Financial Results May 11, 2017 Edwards Lifesciences Corporation Release: German Patent Court Issues Initial Decision March 8, 2017 Catalyst Biosciences To Present At 19th Annual BIO CEO & Investor Conference February 2, 2017
